 |
PDBsum entry 2p94
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
Chains A, L:
E.C.3.4.21.6
- coagulation factor Xa.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Preferential cleavage: Arg-|-Thr and then Arg-|-Ile bonds in prothrombin to form thrombin.
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Bioorg Med Chem Lett
17:4419-4427
(2007)
|
|
PubMed id:
|
|
|
|
|
| |
|
SAR and X-ray structures of enantiopure 1,2-cis-(1R,2S)-cyclopentyldiamine and cyclohexyldiamine derivatives as inhibitors of coagulation Factor Xa.
|
|
J.X.Qiao,
C.H.Chang,
D.L.Cheney,
P.E.Morin,
G.Z.Wang,
S.R.King,
T.C.Wang,
A.R.Rendina,
J.M.Luettgen,
R.M.Knabb,
R.R.Wexler,
P.Y.Lam.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
In the search of Factor Xa (FXa) inhibitors structurally different from the
pyrazole-based series, we identified a viable series of enantiopure
cis-(1R,2S)-cycloalkyldiamine derivatives as potent and selective inhibitors of
FXa. Among them, cyclohexyldiamide 7 and cyclopentyldiamide 9 were the most
potent neutral compounds, and had good anticoagulant activity comparable to the
pyrazole-based analogs. Crystal structures of 7-FXa and 9-FXa illustrate binding
similarities and differences between the five- and the six-membered core
systems, and provide rationales for the observed SAR of P1 and linker moieties.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
Y.K.Lee,
and
M.R.Player
(2011).
Developments in factor Xa inhibitors for the treatment of thromboembolic disorders.
|
| |
Med Res Rev,
31,
202-283.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
|
');
}
}
 |
|